Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Transfusion|March 5, 2021
Frequency of rare, serious donor reactions: International perspectivePampee Young, Lauren Crowder, Whitney Steele, et al.
Transfusion|June 25, 2016
Changes in blood center red blood cell distributions in the era of patient blood management: the trends for collection (TFC) studyMark H Yazer, Bryon Jackson, Neil Beckman, et al.
Transfusion|July 9, 2022
Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storageJose A Cancelas, Jamie R Genthe, Moritz Stolla, et al.
Research Square|May 2, 2025
A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL ExpansionMustafa Khasraw, Kelly Hotchkiss, Kenan Zhang, et al.
Transfusion|February 7, 2018
Changes in plasma unit distributions to hospitals over a 10-year periodJansen N Seheult, Beth Shaz, Marjorie Bravo, et al.
Vox Sanguinis|April 14, 2020
Trends in platelet distributions from 2008 to 2017: a survey of twelve national and regional blood collectorsMark H Yazer, Beth Shaz, Jansen N Seheult, et al.
Trials|November 18, 2020
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.
Trials|June 10, 2020
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.
Trials|June 18, 2020
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialChristina M Eckhardt, Matthew J Cummings, Kartik N Rajagopalan, et al.
The Journal of Clinical Investigation|April 8, 2020
Deployment of convalescent plasma for the prevention and treatment of COVID-19Evan M Bloch, Shmuel Shoham, Arturo Casadevall, et al.
Pageof 5